{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:04Z","timestamp":1792155724543,"version":"4.4.0"},"reference-count":49,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Individual comorbidities have distinct contributions to nonrelapse mortality (NRM) following allogeneic hematopoietic cell transplantation (allo-HCT). We studied the impact of comorbidities individually and in combination in a single-center cohort of 573 adult patients who underwent CD34-selected allo-HCT following myeloablative conditioning. Pulmonary disease, moderate to severe hepatic comorbidity, cardiac disease of any type, and renal dysfunction were associated with increased NRM in multivariable Cox regression models. A Simplified Comorbidity Index (SCI) composed of the 4 comorbidities predictive of NRM, as well as age &amp;gt;60 years, stratified patients into 5 groups with a stepwise increase in NRM. NRM rates ranged from 11.4% to 49.9% by stratum, with adjusted hazard ratios of 1.84, 2.59, 3.57, and 5.38. The SCI was also applicable in an external cohort of 230 patients who underwent allo-HCT with unmanipulated grafts following intermediate-intensity conditioning. The area under the receiver operating characteristic curve (AUC) of the SCI for 1-year NRM was 70.3 and 72.0 over the development and external-validation cohorts, respectively; corresponding AUCs of the Hematopoietic Cell Transplantation\u2013specific Comorbidity Index (HCT-CI) were 61.7 and 65.7. In summary, a small set of comorbidities, aggregated into the SCI, is highly predictive of NRM. The new index stratifies patients into distinct risk groups, was validated in an external cohort, and provides higher discrimination than does the HCT-CI.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004319","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T21:29:48Z","timestamp":1631309388000},"page":"1525-1535","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-8032","authenticated-orcid":false,"given":"Roni","family":"Shouval","sequence":"first","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"2Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Israel;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-1516","authenticated-orcid":false,"given":"Joshua A.","family":"Fein","sequence":"additional","affiliation":[{"name":"4Department of Medicine, University of Connecticut Medical Center, Farmington, CT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Cho","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-9704","authenticated-orcid":false,"given":"Scott T.","family":"Avecilla","sequence":"additional","affiliation":[{"name":"5Department of Laboratory Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josel","family":"Ruiz","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-1061","authenticated-orcid":false,"given":"Ana Alarcon","family":"Tomas","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sanchez-Escamilla","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea Castillo","family":"Flores","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9925-3048","authenticated-orcid":false,"given":"Lucrecia","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet N.","family":"Barker","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-3226","authenticated-orcid":false,"given":"Parastoo","family":"Dahi","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-5053","authenticated-orcid":false,"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander I.","family":"Geyer","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"},{"name":"6Pulmonary Service, Department of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boglarka","family":"Gyurkocza","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann A.","family":"Jakubowski","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-7880","authenticated-orcid":false,"given":"Richard J.","family":"Lin","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"},{"name":"7Bone Marrow Transplant Service, Department of Pediatrics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Politikos","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9422-5766","authenticated-orcid":false,"given":"Doris M.","family":"Ponce","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shaffer","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan L.","family":"Shah","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"6Pulmonary Service, Department of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Tamari","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R. M.","family":"van den Brink","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-6559","authenticated-orcid":false,"given":"James W.","family":"Young","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[{"name":"2Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Devlin","sequence":"additional","affiliation":[{"name":"8Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avichai","family":"Shimoni","sequence":"additional","affiliation":[{"name":"2Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[{"name":"1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;"},{"name":"3Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"issue":"5","key":"2022062913230866800_B1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.6004\/jnccn.2020.7559","article-title":"Eligibility criteria for patients undergoing allogeneic hematopoietic cell transplantation","volume":"18","author":"Kanate","year":"2020","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"2022062913230866800_B2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41409-018-0265-7","article-title":"Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables","volume":"54","author":"Tay","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"2022062913230866800_B3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.bbmt.2017.07.028","article-title":"Prognostic scoring systems in allogeneic hematopoietic stem cell transplantation: where do we stand?","volume":"23","author":"Potdar","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2022062913230866800_B4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis."},{"issue":"8","key":"2022062913230866800_B5","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood."},{"issue":"4","key":"2022062913230866800_B6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/bmt.2011.138","article-title":"Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation","volume":"47","author":"Bokhari","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"2022062913230866800_B7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbmt.2012.10.002","article-title":"Impact of pretransplantation risk factors on post transplantation outcome of patients with acute myeloid leukemia in remission after haploidentical hematopoietic stem cell transplantation","volume":"19","author":"Wang","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"issue":"10","key":"2022062913230866800_B8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbmt.2014.06.005","article-title":"Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy","volume":"20","author":"Nakaya","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"2022062913230866800_B9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbmt.2017.01.003","article-title":"Impact of pretransplantation indices in hematopoietic stem cell transplantation: knowledge of center-specific outcome data is pivotal before making index-based decisions","volume":"23","author":"T\u00f6rl\u00e9n","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"2022062913230866800_B10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41375-018-0185-y","article-title":"The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Fein","year":"2018","journal-title":"Leukemia."},{"issue":"12","key":"2022062913230866800_B11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","article-title":"External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Shouval","year":"2019","journal-title":"Blood Adv."},{"issue":"13","key":"2022062913230866800_B12","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2007-06-096966","article-title":"Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences","volume":"110","author":"Sorror","year":"2007","journal-title":"Blood."},{"issue":"27","key":"2022062913230866800_B13","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1200\/JCO.2006.09.7865","article-title":"Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation","volume":"25","author":"Sorror","year":"2007","journal-title":"J Clin Oncol."},{"issue":"4","key":"2022062913230866800_B14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/bmt.2009.236","article-title":"Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML","volume":"45","author":"Lim","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"2022062913230866800_B15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.13476","article-title":"Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation","volume":"170","author":"ElSawy","year":"2015","journal-title":"Br J Haematol."},{"issue":"11","key":"2022062913230866800_B16","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol."},{"issue":"12","key":"2022062913230866800_B17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/bmt.2017.197","article-title":"Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis","volume":"52","author":"Cho","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"2022062913230866800_B18","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.bbmt.2015.07.010","article-title":"CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse","volume":"21","author":"Tamari","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"2022062913230866800_B19","first-page":"154","article-title":"Allogeneic stem cell transplantation with CD34+ cell selection","volume":"1","author":"Roldan","year":"2019","journal-title":"Clin Hematol Int."},{"issue":"26","key":"2022062913230866800_B20","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2012.41.7071","article-title":"Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation","volume":"30","author":"Pasquini","year":"2012","journal-title":"J Clin Oncol."},{"issue":"9","key":"2022062913230866800_B21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbmt.2011.01.005","article-title":"T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies","volume":"17","author":"Jakubowski","year":"2011","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"2022062913230866800_B22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/10428194.2016.1265113","article-title":"Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant","volume":"58","author":"Goldberg","year":"2017","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"2022062913230866800_B23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13045-018-0668-3","article-title":"Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC","volume":"11","author":"Malard","year":"2018","journal-title":"J Hematol Oncol."},{"issue":"3","key":"2022062913230866800_B24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbmt.2016.12.633","article-title":"Ex vivo CD34+-selected T cell-depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response","volume":"23","author":"Barba","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"2022062913230866800_B25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbmt.2013.02.018","article-title":"Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission","volume":"19","author":"Bayraktar","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"2022062913230866800_B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2016.10.017","article-title":"Hematopoietic cell transplantation comorbidity index predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation","volume":"23","author":"Barba","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"2022062913230866800_B27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/bmt.2014.302","article-title":"Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts","volume":"50","author":"Hobbs","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"2022062913230866800_B28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V91.3.1083","article-title":"T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease","volume":"91","author":"Papadopoulos","year":"1998","journal-title":"Blood."},{"issue":"2","key":"2022062913230866800_B29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions","volume":"93","author":"Small","year":"1999","journal-title":"Blood."},{"issue":"4","key":"2022062913230866800_B30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbmt.2008.02.006","article-title":"Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings","volume":"14","author":"Castro-Malaspina","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"issue":"1","key":"2022062913230866800_B31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbmt.2017.08.033","article-title":"Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34+-selected allogeneic hematopoietic cell transplantation","volume":"24","author":"Scordo","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"2022062913230866800_B32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41409-020-0803-y","article-title":"Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients","volume":"55","author":"Spyridonidis","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"2022062913230866800_B33","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"2022062913230866800_B34","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"5","key":"2022062913230866800_B35","first-page":"BC09","article-title":"Retrospective comparison of estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 hour urine creatinine clearance","volume":"11","author":"Kumar","year":"2017","journal-title":"J Clin Diagn Res."},{"key":"2022062913230866800_B36","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"2022062913230866800_B37"},{"issue":"4","key":"2022062913230866800_B38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation."},{"issue":"4","key":"2022062913230866800_B39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol."},{"issue":"30","key":"2022062913230866800_B40","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med."},{"issue":"4","key":"2022062913230866800_B41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003\u20132007 versus 2013\u20132017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med."},{"issue":"3","key":"2022062913230866800_B42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1164\/rccm.200502-212OC","article-title":"Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation","volume":"172","author":"Parimon","year":"2005","journal-title":"Am J Respir Crit Care Med."},{"issue":"12","key":"2022062913230866800_B43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.bbmt.2006.07.016","article-title":"Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation","volume":"12","author":"Savani","year":"2006","journal-title":"Biol Blood Marrow Transplant."},{"issue":"12","key":"2022062913230866800_B44","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1200\/JCO.1998.16.12.3796","article-title":"Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients","volume":"16","author":"Goldberg","year":"1998","journal-title":"J Clin Oncol."},{"issue":"8","key":"2022062913230866800_B45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.bbmt.2018.05.005","article-title":"Baseline renal function and albumin are powerful predictors for allogeneic transplantation-related mortality","volume":"24","author":"Shouval","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"2022062913230866800_B46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbmt.2015.01.011","article-title":"Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation","volume":"21","author":"Au","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"issue":"29","key":"2022062913230866800_B47","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.2013.53.8157","article-title":"Comorbidity-Age Index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation","volume":"32","author":"Sorror","year":"2014","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022062913230866800_B48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41409-019-0654-6","article-title":"Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies","volume":"55","author":"Lin","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"2022062913230866800_B49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/cs0420325","article-title":"Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during sub-maximal exercise","volume":"42","author":"Cotes","year":"1972","journal-title":"Clin Sci."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/5\/1525\/1905094\/advancesadv2021004319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/5\/1525\/1905094\/advancesadv2021004319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:24:14Z","timestamp":1656509054000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/5\/1525\/476859\/The-Simplified-Comorbidity-Index-a-new-tool-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004319","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]}}}